Becton, Dickinson and Co. | BDX - Ebitda

Preço das Ações
152.13
Mudança Diária
-2.72 -1.76%
Mensal
-3.88%
Anual
-25.82%
Q2 Previsão
155.05




Ebitda Alterar Data
Abbott USD 3.27B 178M 2025-12
Agilent USD 540M 74M 2025-09
Align Technology USD 183.84M 19.77M 2025-09
AngioDynamics USD 5.94M 3.78M 2025-09
Avanos Medical USD 10M 73.9M 2025-09
Baxter International USD 426M 36M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio-Rad Laboratories USD -374.6M 841.8M 2025-09
Boston Scientific USD 1.16B 213M 2025-12
Cooper Companies USD 323.4M 13.2M 2025-12
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 135M 32M 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Globus Medical USD 280.46M 27.86M 2025-12
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intuitive Surgical USD 1.09B 165.5M 2025-12
J&J USD 7.19B 2.32B 2025-12
Masimo USD 91.9M 19.9M 2025-09
Medtronic USD 2.93B 482M 2025-12
Solventum Corp USD 437M 38M 2025-12
Stryker USD 1.67B 206M 2025-09
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD -328.81M 536.43M 2025-09
Terumo JPY 69.99B 3.22B 2025-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Zimmer Biomet Holdings USD 759M 120.8M 2025-12